Send the following on WhatsApp
Continue to ChatUPDATED: Incyte nabs approval of topical ruxolitinib in atopic dermatitis, but gets slapped with JAK warning https://invesbrain.com/updated-incyte-nabs-approval-of-topical-ruxolitinib-in-atopic-dermatitis-but-gets-slapped-with-jak-warning/